Privia Health Group (NASDAQ:PRVA – Get Free Report) posted its earnings results on Thursday. The company reported $0.29 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.23, Briefing.com reports. The business had revenue of $580.42 million during the quarter, compared to the consensus estimate of $494.98 million. Privia Health Group had a return on equity of 2.52% and a net margin of 0.89%.The business’s quarterly revenue was up 32.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.20 EPS. Privia Health Group updated its FY 2025 guidance to EPS.
Privia Health Group Price Performance
PRVA traded down $0.55 during trading hours on Friday, hitting $23.43. 1,382,680 shares of the stock were exchanged, compared to its average volume of 791,019. Privia Health Group has a 12 month low of $18.77 and a 12 month high of $26.51. The stock has a 50-day simple moving average of $24.15 and a 200-day simple moving average of $22.77. The stock has a market cap of $2.88 billion, a price-to-earnings ratio of 180.24, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83.
Hedge Funds Weigh In On Privia Health Group
Several institutional investors have recently made changes to their positions in PRVA. Qube Research & Technologies Ltd increased its position in Privia Health Group by 93.3% during the second quarter. Qube Research & Technologies Ltd now owns 609,278 shares of the company’s stock worth $14,013,000 after acquiring an additional 294,101 shares during the period. Cubist Systematic Strategies LLC acquired a new stake in Privia Health Group during the second quarter valued at approximately $6,219,000. First Trust Advisors LP grew its position in Privia Health Group by 482.7% in the second quarter. First Trust Advisors LP now owns 279,005 shares of the company’s stock valued at $6,417,000 after acquiring an additional 231,125 shares during the period. PDT Partners LLC grew its holdings in shares of Privia Health Group by 152.8% in the 2nd quarter. PDT Partners LLC now owns 218,679 shares of the company’s stock worth $5,030,000 after purchasing an additional 132,180 shares during the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Privia Health Group by 63.5% during the first quarter. Royal Bank of Canada now owns 245,633 shares of the company’s stock worth $5,514,000 after buying an additional 95,371 shares in the last quarter. 94.48% of the stock is owned by institutional investors.
Analyst Ratings Changes
Read Our Latest Report on Privia Health Group
Privia Health Group Company Profile
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Read More
- Five stocks we like better than Privia Health Group
- Conference Calls and Individual Investors
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- How to Invest in the FAANG Stocks
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- What Is WallStreetBets and What Stocks Are They Targeting?
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
